[HTML][HTML] Biomarkers of cytokine storm as red flags for severe and fatal COVID-19 cases: A living systematic review and meta-analysis

AKG Melo, KM Milby, ALMA Caparroz, ACPN Pinto… - PloS one, 2021 - journals.plos.org
Objective To describe the laboratory parameters and biomarkers of the cytokine storm
syndrome associated with severe and fatal COVID-19 cases. Methods A search with …

[HTML][HTML] Understanding the role of ACE-2 receptor in pathogenesis of COVID-19 disease: a potential approach for therapeutic intervention

E Shirbhate, J Pandey, VK Patel, M Kamal… - Pharmacological …, 2021 - Springer
Angiotensin-converting enzyme (ACE) and its homologue, ACE2, are commonly allied with
hypertension, renin–angiotensin–aldosterone system pathway, and other cardiovascular …

[HTML][HTML] Factors associated with mortality in patients with COVID-19. A quantitative evidence synthesis of clinical and laboratory data

PR Martins-Filho, CSS Tavares… - European journal of …, 2020 - ncbi.nlm.nih.gov
The COVID-19 pandemic caused by the severe acute respiratory coronavirus 2 (SARS-CoV-
2) has become a serious challenge for health systems worldwide. Despite the favorable …

Commentary: COVID-19 and diabetes mellitus: What we know, how our patients should be treated now, and what should happen next

AM Angelidi, MJ Belanger… - Metabolism-Clinical …, 2020 - metabolismjournal.com
The novel coronavirus disease (COVID-19) caused by severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) has evolved into a worldwide crisis and was declared a global …

[HTML][HTML] Early experience of an infectious and tropical diseases unit during the coronavirus disease (COVID-19) pandemic, Florence, Italy, February to March 2020

F Lagi, M Piccica, L Graziani, I Vellere, A Botta… - …, 2020 - eurosurveillance.org
We analysed the first 84 coronavirus disease (COVID-19) patients hospitalised in an
infectious and tropical disease unit in Florence, Italy, over 30 days after the start of the …

Systematic review of the prognostic utility of D-dimer, disseminated intravascular coagulation, and anticoagulant therapy in COVID-19 critically ill patients

G Moreno, R Carbonell, M Bodí, A Rodríguez - Medicina Intensiva (English …, 2021 - Elsevier
During the new pandemic caused by SARS-CoV-2, there is short knowledge regarding the
management of different disease areas, such as coagulopathy and interpretation of D-dimer …

[HTML][HTML] Why is SARS-CoV-2 infection milder among children?

P Palmeira, JAM Barbuto, CAA Silva… - Clinics, 2020 - SciELO Brasil
Acute respiratory viral diseases, like most other infectious diseases, affect mainly infants and
young children, who present with 6-8 episodes per year and usually develop more severe …

Factores de riesgo de mortalidad en pacientes mayores de 65 años hospitalizados por COVID-19

JMF Ibáñez, MCM Ballesteros, MÁG Andúgar… - Revista Española de …, 2022 - Elsevier
Antecedentes y objetivo COVID-19 es una enfermedad causada por el coronavirus 2 del
síndrome respiratorio agudo grave (SARS-CoV-2), que ha provocado una pandemia que …

[HTML][HTML] COVID-19 и его осложнения

АХ Абдурахимов, ЛН Хегай, ШК Юсупова - Re-health journal, 2021 - cyberleninka.ru
COVID-19 способен вызывать тяжелые осложнения со стороны сердца, легких, мозга,
почек, сосудов и других жизненно важных систем и органов человека. Хотя COVID-19 и …

[HTML][HTML] SARS-CoV-2 infection induces mixed M1/M2 phenotype in circulating monocytes and alterations in both dendritic cell and monocyte subsets

S Matic, S Popovic, P Djurdjevic, D Todorovic… - PLoS …, 2020 - journals.plos.org
Clinical manifestations of SARS-CoV-2 infection range from mild to critically severe. The aim
of the study was to highlight the immunological events associated with the severity of SARS …